Pregled bibliografske jedinice broj: 510475
Morbidly Obese are Ghrelin and Leptin Hyporesponders with Lesser Intragastric Balloon Treatment Efficiency : Ghrelin and Leptin Changes in Relation to Obesity Treatment.
Morbidly Obese are Ghrelin and Leptin Hyporesponders with Lesser Intragastric Balloon Treatment Efficiency : Ghrelin and Leptin Changes in Relation to Obesity Treatment. // Obesity surgery, 21 (2011), 10; 1597-1604 doi:10.1007/s11695-011-0414-1 (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 510475 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Morbidly Obese are Ghrelin and Leptin Hyporesponders with Lesser Intragastric Balloon Treatment Efficiency : Ghrelin and Leptin Changes in Relation to Obesity Treatment.
Autori
Nikolić, Marko ; Boban, Marko ; Ljubičić, Neven ; Supanc, Vladimir ; Mirošević, Gorana ; Pezo Nikolić, Borka ; Krpan, Ružica ; Posavec, Ljubica ; Zjačić-Rotkvić, Vanja ; Bekavac-Bešlin, Miroslav ; Gaćina, Petar
Izvornik
Obesity surgery (0960-8923) 21
(2011), 10;
1597-1604
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
BIB; IB- BioEnterics intragastric balloon; non morbid obesity; morbid obesity; BMI- body mass index; ghrelin; leptin; treatment efficiency; treatment resistance
Sažetak
Ghrelin and leptin recently emerged as the most influential neuroendocrine factors in the pathophysiology of obesity. The said peptides act in reciprocity and are responsible for regulation of appetite and energy metabolism. Intragastric balloons acquired worldwide popularity for obesity treatment. However, the roles of ghrelin and leptin in intragastric balloon treatment were still not systematically studied. A prospective single-center study included 43 Caucasians treated with BioEnterics intragastric balloon, with age range of 18-60, and divided to non-morbid (body mass index cutoff 40 kg/m(2)) or morbid type of obesity, with 12 months follow-up. Serum hormonal samples were taken from fasting patients and kept frozen until analyses. Significant differences were observed in anthropometrics and there were no differences between genders or comorbidities. The baseline weight for non-morbid vs. morbid was 104 kg (90- 135) vs. 128.5 kg (104-197). Weight loss was statistically different between the studied groups during the study course with a median control weight at 6 months of 92 kg (72-121) vs. 107 kg (84-163), p < 0.001. Treatment was successful for 18 (94.7%) vs. 16 (66.7%) patients, p = 0.026. Ghrelin varied from 333.3 to 3, 416.8 pg/ml and leptin from 1.7 to 61.2 ng/ml, with a statistically significant time-dependent relationship. A significant difference (p = 0.04) with emphasized ghrelin peak was found in the 3rd month of treatment for non-morbidly obese subjects. The importance of ghrelin and leptin in treatment-induced changes was reaffirmed. Ghrelin hyper-response in non-morbidly obese subjects characterized greater short-term treatment efficiency and landmarked an inclination to weight regain. The results suggest a potential pattern of individualization between obese patients according to body mass index towards intragastric balloon or bariatric surgery. Further studies are needed in order to get better insights in the pathophysiologic mechanisms of obesity.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
POVEZANOST RADA
Ustanove:
KBC "Sestre Milosrdnice"
Profili:
Vladimir Supanc
(autor)
Petar Gaćina
(autor)
Ružica Krpan
(autor)
Gorana Mirošević
(autor)
Ljubica Posavec
(autor)
Miroslav Bekavac-Bešlin
(autor)
Neven Ljubičić
(autor)
Vanja Zjačić-Rotkvić
(autor)
Marko Nikolić
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE